hplc system gilson model 307 pump (Gilson Inc)
Gilson Inc is a verified supplier 
Gilson Inc manufactures this product 
90
Structured Review
Gilson Inc
hplc system gilson model 307 pump
Hplc System Gilson Model 307 Pump, supplied by Gilson Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+307+gilson+pump/hplc+gilson/10__1007_slash_s40005___024___00710___w-78-1-5
Average 90 stars, based on 1 article reviews
Hplc System Gilson Model 307 Pump, supplied by Gilson Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/model+307+gilson+pump/hplc+gilson/10__1007_slash_s40005___024___00710___w-78-1-5
Average 90 stars, based on 1 article reviews
hplc system gilson model 307 pump - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Article Snippet: Rationale: Acute morphine and abstinence from chronic morphine have been shown to increase and to decrease extracellular dopamine (DA) in the nucleus accumbens, respectively.. In contrast, extracellular DA in the prefrontal cortex (PFC) is not modified by acute morphine and is markedly increased during abstinence syndrome.. Objectives: We investigated whether the peculiar behaviour of PFC DA might depend on the fact that extracellular DA originates not only from DA but, mainly, noradrenaline (NA) terminals. Article Title: Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. Article Snippet: The mobile phase consisted of 80 mM Article Title: Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Article Snippet: Rationale: Clozapine has been shown to increase extracellular dopamine (DA) and noradrenaline (NA) in the medial prefrontal cortex (mPFC).. A recent study of ours suggested that extracellular DA in the PFC originates not only from dopaminergic but also from noradrenergic terminals, its release being controlled by a2-adrenoceptors.. Objectives: Since clozapine binds to a2-adrenoceptors, the possibility that it might co-release DA and NA was studied. Article Title: Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Article Snippet: The mobile phase consisted of 80 mM Na2HPO4, 0.27 mM EDTA, 0.58 mM sodium octyl sulphate, 12% methanol, pH 2.8 with H3PO4, delivered by a Article Title: Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus Article Snippet: The mobile phase consisted of 80 mM Na 2 HPO 4 , 0.27 mM EDTA, 0.58 mM sodium octyl sulphate, 12% methanol, pH 2.8 with H 3 PO 4 , delivered by a |